PPD, Inc. (PPDI) Earns Highest Ratings for Customer Loyalty and Overall Value Among Phase I Providers in ISR Report
8/1/2012 9:11:11 AM
WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) has earned the highest ratings in customer loyalty, overall value and several other attributes for Phase I services according to an Industry Standard Research (ISR) study, which evaluated 12 Phase I providers across nine key areas. In its new report, “2012 CRO Quality Benchmarking – Phase I Service Providers,” ISR surveyed 61 pharmaceutical executives responsible for Phase I outsourcing. In the survey, PPD received the highest rating for customer loyalty, a result of its top scores for overall satisfaction, willingness to recommend and likelihood to use again. In addition, PPD received the highest marks for five of ISR’s nine service attributes, including overall value, technical expertise, breadth of services, meeting schedules and timelines, and quality of the Phase I unit’s lead investigator—demonstrating that the company’s performance surpasses customer expectations.